Cargando…
Potential Mechanism Underlying the Role of Mitochondria in Breast Cancer Drug Resistance and Its Related Treatment Prospects
Breast cancer incidence and mortality rates have been consistently high among women. The use of diverse therapeutic strategies, including chemotherapy, endocrine therapy, targeted therapy, and immunotherapy, has improved breast cancer prognosis. However, drug resistance has become a tremendous obsta...
Autores principales: | Li, Yuefeng, Li, Zhian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013997/ https://www.ncbi.nlm.nih.gov/pubmed/33816265 http://dx.doi.org/10.3389/fonc.2021.629614 |
Ejemplares similares
-
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
por: Panina, Svetlana B., et al.
Publicado: (2020) -
The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
por: Tian, Jin-hai, et al.
Publicado: (2021) -
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
por: Zhou, Xuehao, et al.
Publicado: (2022) -
Extrachromosomal circular DNA in cancer drug resistance and its potential clinical implications
por: Luo, Juanjuan, et al.
Publicado: (2023) -
Role of Ubiquitination in PTEN Cellular Homeostasis and Its Implications in GB Drug Resistance
por: Xia, Qin, et al.
Publicado: (2020)